Tovoli F.; De Lorenzo S.; Trevisani F., Immunotherapy with checkpoint inhibitors for hepatocellular carcinoma: Where are we now?, «VACCINES», 2020, 8, Article number: 578 , pp. 1 - 21 [Scientific article]Open Access
Elisabetta Goio; Luca Ielasi; Francesca Benevento; Matteo Renzulli; Francesco Tovoli, Long-lasting remission in a metastatic hepatocellular carcinoma patient after combined regorafenib therapy and surgery, «HEPATIC ONCOLOGY», 2020, 7, Article number: HEP24 , pp. 1 - 6 [Scientific article]Open Access
De Lorenzo S.; Tovoli F.; Mazzotta A.; Vasuri F.; Edeline J.; Malvi D.; Boudjema K.; Renzulli M.; Jeddou H.; D'errico A.; Turlin B.; Cescon M.; Uguen T.; Granito A.; Lievre A.; Brandi G., Non-alcoholic steatohepatitis as a risk factor for intrahepatic cholangiocarcinoma and its prognostic role, «CANCERS», 2020, 12, Article number: 3182 , pp. 1 - 14 [Scientific article]Open Access
Orsi G.; Tovoli F.; Dadduzio V.; Vivaldi C.; Brunetti O.; Ielasi L.; Conti F.; Rovesti G.; Gramantieri L.; Rizzato M.D.; Pecora I.; Argentiero A.; Teglia F.; Lonardi S.; Salani F.; Granito A.; Zagonel V.; Marisi G.; Cabibbo G.; Foschi F.G.; Benevento F.; Cucchetti A.; Piscaglia F.; Cascinu S.; Scartozzi M.; Casadei-Gardini A., Prognostic Role of Blood Eosinophil Count in Patients with Sorafenib-Treated Hepatocellular Carcinoma, «TARGETED ONCOLOGY», 2020, 15, pp. 773 - 785 [Scientific article]
Tovoli F.; Guerra P.; Iavarone M.; Veronese L.; Renzulli M.; De Lorenzo S.; Benevento F.; Brandi G.; Stefanini F.; Piscaglia F., Surveillance for Hepatocellular Carcinoma Also Improves Survival of Incidentally Detected Intrahepatic Cholangiocarcinoma Arisen in Liver Cirrhosis, «LIVER CANCER», 2020, 11, pp. 1 - 12 [Scientific article]Open Access
Sansone V.; Le Grazie M.; Roselli J.; Polvani S.; Galli A.; Tovoli F.; Tarocchi M., Telomerase reactivation is associated with hepatobiliary and pancreatic cancers, «HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL», 2020, 19, pp. 420 - 428 [Scientific article]
Francesco Caputo,Vincenzo Dadduzio,Francesco Tovoli,Giulia Bertolini,Giuseppe Cabibbo,Krisida Cerma,Caterina Vivaldi,Luca Faloppi,Mario Domenico Rizzato,Fabio Piscaglia,Ciro Celsa,Lorenzo Fornaro,Giorgia Marisi,Fabio Conti,Nicola Silvestris,Marianna Silletta,Sara Lonardi,Alessandro Granito,Caterina Stornello,Valentina Massa,Giorgio Astara,Sabina Delcuratolo,Stefano Cascinu,Mario Scartozzi,Andrea Casadei-Gardini, The role of PNI to predict survival in advanced hepatocellular carcinoma treated with Sorafenib, «PLOS ONE», 2020, 15, Article number: e0232449 , pp. 1 - 13 [Scientific article]Open Access
Leoni S.; Sansone V.; De Lorenzo S.; Ielasi L.; Tovoli F.; Renzulli M.; Golfieri R.; Spinelli D.; Piscaglia F., Treatment of combined hepatocellular and cholangiocarcinoma, «CANCERS», 2020, 12, Article number: 794 , pp. 794 - 809 [Scientific article]Open Access
Brandi G.; Rizzo A.; Deserti M.; Relli V.; Indio V.; Bin S.; Pariali M.; Palloni A.; De Lorenzo S.; Tovoli F.; Tavolari S., Wilson disease, ABCC2 c.3972C > T polymorphism and primary liver cancers: suggestions from a familial cluster, «BMC MEDICAL GENETICS», 2020, 21, Article number: 225 , pp. 225 - 230 [Scientific article]Open Access
Renzulli M.; Clemente A.; Tovoli F.; Cappabianca S.; Bolondi L.; Golfieri R., Hepatocellular adenoma: An unsolved diagnostic enigma, «WORLD JOURNAL OF GASTROENTEROLOGY», 2019, 25, pp. 2442 - 2449 [Scientific article]Open Access
Renzulli, M.; Zanotti, S.; Clemente, A.; Mineo, G.; Tovoli, F.; Reginelli, A.; Barile, A.; Cappabianca, S.; Taffurelli, M.; Golfieri, R., Hereditary breast cancer: Screening and risk reducing surgery, «GLAND SURGERY», 2019, 8, pp. S142 - S149 [Scientific article]
Ielasi, L.; Goio, E.; Tovoli, F., Hot topics in hepatocellular carcinoma, «TRANSLATIONAL CANCER RESEARCH», 2019, 8, pp. S216 - S218 [Scientific article]Open Access
Sagrini, E.; Iavarone, M.; Stefanini, F.; Tovoli, F.; Vavassori, S.; Maggioni, M.; Renzulli, M.; Salvatore, V.; Stefanescu, H.; Colombo, M.; Bolondi, L.; Piscaglia, F., Imaging of combined hepatocellular-cholangiocarcinoma in cirrhosis and risk of false diagnosis of hepatocellular carcinoma, «UNITED EUROPEAN GASTROENTEROLOGY JOURNAL», 2019, 7, pp. 69 - 77 [Scientific article]
Tovoli F.; Casadei-Gardini A.; Benevento F.; Piscaglia F., Immunotherapy for hepatocellular carcinoma: A review of potential new drugs based on ongoing clinical studies as of 2019, «DIGESTIVE AND LIVER DISEASE», 2019, 51, pp. 1067 - 1073 [Scientific article]
Ielasi, L.; Tovoli, F.; Piscaglia, F., Lenvatinib mesylate to treat hepatocellular carcinoma, «DRUGS OF TODAY», 2019, 55, pp. 305 - 313 [Scientific article]
